Loading...
XKRX003580
Market cap147mUSD
Jan 06, Last price  
4,435.00KRW
1D
1.95%
1Q
-7.80%
Jan 2017
1.37%
Name

HLB Global Co Ltd

Chart & Performance

D1W1MN
XKRX:003580 chart
P/E
—
P/S
2.71
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
15.42%
Rev. gr., 5y
43.25%
Revenues
79.87b
+79.10%
15,149,890,00014,119,363,00015,528,235,00017,550,218,00023,387,119,53021,625,906,21019,571,563,82022,864,464,29015,301,017,60018,255,840,70015,686,212,20013,237,690,41035,025,713,00035,376,821,51045,046,153,03044,591,899,19079,865,665,760
Net income
-22.81b
L+49.63%
-4,551,187,000-4,801,801,000-3,527,865,000-9,160,454,000-9,661,787,000-4,034,580,000-7,340,389,780-658,507,610216,540,570-2,299,975,000-739,375,000-11,293,884,000-22,868,904,500-28,407,071,920-13,082,245,470-15,243,254,200-22,808,276,820
CFO
-12.71b
L+57.36%
-717,390,000-9,294,228,000-3,067,257,0001,223,810,0002,979,339,180-42,653,140360,562,1003,733,087,9901,040,872,650-1,985,564,450598,786,290572,706,700-6,417,304,370-13,329,683,190-5,959,773,770-8,079,585,750-12,713,654,140

Profile

HLB GLOBAL Co., Ltd. engages in the sea sand extraction business in South Korea. Its marine sand production process includes departure, extraction, berthing, discharging, sorting, washing, and shipment. The company also collects aggregates from under the sea, such as gravel, sand, mixed and fine aggregates, asphalt, concrete, and others. In addition, it offers a range of products, including color cosmetics, hair products, and denim jeans in the United States, China, and Japan. Further, the company develops drugs for infectious diseases, such as sepsis, influenza, and viral hepatitis; and immunological diseases, including rheumatoid arthritis and others. The company was formerly known as NEXT SCIENCE Co., Ltd. and changed its name to HLB GLOBAL Co., Ltd. in April 2022. HLB GLOBAL Co., Ltd. was founded in 1962 and is headquartered in Sabuk-eup, South Korea.
URL
http://hlbglobal.co.kr/
IPO date
Mar 23, 1990
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
79,865,666
79.10%
44,591,899
-1.01%
Cost of revenue
83,275,949
48,359,668
Unusual Expense (Income)
NOPBT
(3,410,283)
(3,767,769)
NOPBT Margin
Operating Taxes
(725,446)
(146,268)
Tax Rate
NOPAT
(2,684,837)
(3,621,501)
Net income
(22,808,277)
49.63%
(15,243,254)
16.52%
Dividends
Dividend yield
Proceeds from repurchase of equity
103,500
1,473,572
BB yield
-0.05%
-0.64%
Debt
Debt current
31,513,561
34,922,593
Long-term debt
9,787,388
2,207,702
Deferred revenue
Other long-term liabilities
6,252,180
1,264,796
Net debt
(4,863,889)
(13,318,449)
Cash flow
Cash from operating activities
(12,713,654)
(8,079,586)
CAPEX
(1,106,156)
(1,996,607)
Cash from investing activities
(3,987,332)
30,364,254
Cash from financing activities
10,419,957
(15,340,632)
FCF
(7,847,336)
(6,650,151)
Balance
Cash
9,848,577
28,629,417
Long term investments
36,316,261
21,819,327
Excess cash
42,171,554
48,219,150
Stockholders' equity
(126,885,751)
(70,164,949)
Invested Capital
224,938,072
175,986,966
ROIC
ROCE
EV
Common stock shares outstanding
42,367
42,251
Price
5,020.00
-8.23%
5,470.00
-74.91%
Market cap
212,682,516
-7.97%
231,111,258
-72.41%
EV
210,349,004
221,974,596
EBITDA
2,406,089
1,979,338
EV/EBITDA
87.42
112.15
Interest
5,830,726
5,291,756
Interest/NOPBT